Diminazene Ameliorates Neuroinflammation by Suppression of Astrocytic miRNA-224-5p/NLRP3 Axis in Alzheimer’s Disease Model

[1]  Ying-Dong Zhang,et al.  AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway , 2021, Brain sciences.

[2]  Xiuyong Cheng,et al.  miR-141-3p inhibits the activation of astrocytes and the release of inflammatory cytokines in bacterial meningitis through down-regulating HMGB1 , 2021, Brain Research.

[3]  D. Serón,et al.  [The renin-angiotensin system and the brain]. , 2021, Hipertension y riesgo vascular.

[4]  T. Jiang,et al.  ACE2 activator diminazene aceturate ameliorates Alzheimer's disease-like neuropathology and rescues cognitive impairment in SAMP8 mice , 2020, Aging.

[5]  Ming Wang,et al.  miR-194-5p inhibits LPS-induced astrocytes activation by directly targeting neurexophilin 1 , 2020, Molecular and Cellular Biochemistry.

[6]  Jing Feng,et al.  Blocking the LncRNA MALAT1/miR-224-5p/NLRP3 Axis Inhibits the Hippocampal Inflammatory Response in T2DM With OSA , 2020, Frontiers in Cellular Neuroscience.

[7]  E. Hamel,et al.  Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease , 2020, Neurobiology of Disease.

[8]  M. Good,et al.  ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease , 2020, Acta Neuropathologica.

[9]  Chih‐Chung Lin,et al.  Lipopolysaccharide-Induced Matrix Metalloproteinase-9 Expression Associated with Cell Migration in Rat Brain Astrocytes , 2019, International journal of molecular sciences.

[10]  Jun-Hwan Lee,et al.  Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model , 2019, Journal of Neuroinflammation.

[11]  R. Perneczky,et al.  Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid , 2019, Alzheimer's & Dementia.

[12]  Nicholas M. Wragg,et al.  Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease , 2019, Molecular Neurobiology.

[13]  Nicola J. Ray,et al.  Neuroinflammation in mild cognitive impairment and Alzheimer’s disease: A meta-analysis , 2019, Ageing Research Reviews.

[14]  D. Shang,et al.  Emodin attenuated severe acute pancreatitis via the P2X ligand-gated ion channel 7/NOD-like receptor protein 3 signaling pathway , 2018, Oncology reports.

[15]  J. Schulz,et al.  α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1–42-stimulated murine astrocytes , 2018, Journal of Neuroinflammation.

[16]  Yunyi Yao,et al.  Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes , 2018, Molecular medicine reports.

[17]  Marwan Emara,et al.  Stimulation of ACE2/ANG(1–7)/Mas Axis by Diminazene Ameliorates Alzheimer’s Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway , 2018, Molecular Neurobiology.

[18]  A. Ergul,et al.  Within the Brain: The Renin Angiotensin System , 2018, International journal of molecular sciences.

[19]  Siranjeevi Nagaraj,et al.  microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer , 2019, Ageing Research Reviews.

[20]  M. Millan.  Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: An integrative review , 2017, Progress in Neurobiology.

[21]  B. Barres,et al.  Reactive Astrocytes: Production, Function, and Therapeutic Potential. , 2017, Immunity.

[22]  George T Grossberg,et al.  Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics , 2017, Expert review of neurotherapeutics.

[23]  Manish Putteeraj,et al.  MicroRNA Dysregulation in Alzheimer's Disease. , 2017, CNS & neurological disorders drug targets.

[24]  P. Kehoe,et al.  Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology , 2016, Alzheimer's Research & Therapy.

[25]  J. Hardy,et al.  Neurobiology of Alzheimer’s Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions , 2015, Current Alzheimer research.

[26]  R. Morishita,et al.  Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy , 2014, Front. Aging Neurosci..

[27]  V. Perry,et al.  Microglial priming in neurodegenerative disease , 2014, Nature Reviews Neurology.

[28]  V. Kim,et al.  Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.

[29]  C. Holmes.  Review: Systemic inflammation and Alzheimer's disease , 2013, Neuropathology and applied neurobiology.

[30]  R. Santos,et al.  Angiotensin‐converting enzyme 2: a new target for neurogenic hypertension , 2010, Experimental physiology.

[31]  Kate Schroder,et al.  The NLRP3 Inflammasome: A Sensor for Metabolic Danger? , 2010, Science.

[32]  A. Delacourte,et al.  MicroRNA regulation of Alzheimer's Amyloid precursor protein expression , 2009, Neurobiology of Disease.